Skip to main content

Sotalol News

Use of Nonselective β-Blockers Tied to Lower Risk for Total Knee Arthroplasty

FRIDAY, Sept. 15, 2023 – The use of nonselective β-blockers is associated with a lower likelihood of undergoing total knee arthroplasty (TKA), according to a study published online Sept. 5 in the ...

Arbor Pharmaceuticals Announces FDA Approval of Sotylize

Atlanta, GA — October 23,2014 – Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Sotylize (sotalol h...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Atrial Fibrillation

Sotalol patient information at Drugs.com